Outcomes of patients with metastatic clear-cell renal cell carcinoma treated with pazopanib after disease progression with other targeted therapies von Matrana, M.R, Duran, C, Shetty, A, Xiao, L, Atkinson, B.J, Corn, P, Pagliaro, L.C, Millikan, R.E, Charnsangave, C, Jonasch, E, Tannir, N.M

Volltext

Penile cancer: current therapy and future directions von Sonpavde, G., Pagliaro, L.C., Buonerba, C., Dorff, T.B., Lee, R.J., Di Lorenzo, G.

Volltext

Outcome of patients with metastatic renal cell carcinoma treated with targeted therapy without cytoreductive nephrectomy von Richey, S.L., Culp, S.H., Jonasch, E., Corn, P.G., Pagliaro, L.C., Tamboli, P., Patel, K.K., Matin, S.F., Wood, C.G., Tannir, N.M.

Volltext

Integrating chemohormonal therapy and surgery in known or suspected lymph node metastatic prostate cancer von Zurita, A J, Pisters, L L, Wang, X, Troncoso, P, Dieringer, P, Ward, J F, Davis, J W, Pettaway, C A, Logothetis, C J, Pagliaro, L C

Volltext

625 THE SPECIFIC CLINICAL CHARACTERISTICS OF DUCTAL PROSTATE CANCER von Leibovici, D, Tu, S.M, Lopez, A, Pagliaro, L.C, Kuban, D.A, Logothetis, C.J, Pisters, L.L

Volltext

Integrating chemohormonal therapy and surgery in known or suspected lymph node metastatic prostate cancer von Zurita, A.J, Pisters, L.L, Wang, X, Troncoso, P, Dieringer, P, Ward, J.F, Davis, J.W, Pettaway, C.A, Logothetis, C.J, Pagliaro, L.C

Volltext

Nuclear export inhibitors and kinase inhibitors identified using a MAPK-activated protein kinase 2 redistribution screen von Almholt, Dorthe L C, Loechel, Frosty, Nielsen, Søren J, Krog-Jensen, Christian, Terry, Robert, Bjørn, Sara P, Pedersen, Hans C, Praestegaard, Morten, Møller, Søren, Heide, Morten, Pagliaro, Len, Mason, Anthony J, Butcher, Steven, Dahl, Søren W

Volltext